Dentalum considers new issue of shares and presents financial targets for the group as well as plans for public listing

Report this content

Dentalum Operations AB (publ) ("Dentalum" or "the Company") has engaged Pareto Securities AB to investigate the possibility of carrying out a private placement in Dentalum Group AB to a limited group of investors. In connection with this, the Board of Directors of the Company have adopted financial targets for the period 2022-2024 and states its intention to list the Company's shares on a regulated market or multilateral trading platform (MTF) within 18 months.

New share issue

Dentalum has continued to deliver in accordance with its growth strategy and has a strong acquisition pipeline as a result of a well-planned offensive strategy for market penetration in Sweden. To promote the Company's continued growth, Dentalum has engaged Pareto Securities AB to investigate the conditions for conducting a private placement of shares In Dentalum Group AB to a limited group of investors. The net proceeds from the private placement will be used to finance the Company's continued growth through the acquisition of new clinics and investments in existing clinics to continue to create value for the Company's shareholders, co-workers, patients and other stakeholders.

Plans for public listing

The Board of Dentalum Group AB have declared the intention to list the Dentalum Group AB's shares on a regulated market or multilateral trading platform (MTF) within 18 months.

Financial targets for the period 2022-2024

The financial targets presented below have been developed to reflect both the development of the industry and the Company's forecast organic- and acquisition-based growth.

  • EBITDA: Dentalum’s target is to reach SEK 280m in proforma and adjusted EBITDA1 by the end of 2024.
  • EBITDA-margin: Dentalum’s target is to continue having a sustainable and high profitability exceeding an average annual adjusted EBITDA-margin of 20%.2

“Within two years, Dentalum has become one of the leading dental service organisations in Sweden. We have the privilege to work with skilled and motivated co-workers that provide patients with high-quality dental care. Dentalum is well positioned, both from a financial position as well as strategical, to continue its rapid expansion through acquisitions of well-renowned, sustainable and profitable clinics. The planned private placement and our ambition to list Dentalum will thus be a natural next step in the continued growth journey”, says Robin Rutili, co-founder and Chairman of the Board of Dentalum.

For more information, please contact:

Max Dorthé Ladow, CEO and co-founder, +46 709 85 97 83, max.ladow@dentalum.com 
Sofi Eriksson, CFO, +46 705 95 46 33, sofi.eriksson@dentalum.com

Visit www.dentalum.com

About Dentalum

Dentalum Operations AB (publ) is a fast-growing dental service organisation focusing on acquiring profitable and sustainable dental clinics in the Nordics. Dentalum’s philosophy is built on local heritage, where the clinic owners continue as entrepreneurs operating the clinics with a high degree of independence post-acquisition. Dentalum’s goal is to build a world class organisation by creating a strong corporate culture, positive work environment and growth opportunities which motivate and engage our coworkers to provide the highest quality of care and a remarkable service to our patients. For more information, please visit www.dentalum.com

This is information that Dentalum Operations AB (publ) is obliged to make public pursuant to EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 9.00 a.m. CET on November 22, 2021.

1) Earnings before Interest Tax Depreciations & Amortizations according to IFRS, adjusted for non-recurring income and expense, identified as not related to the dental operations of the acquired entities, and excluding any transaction costs. Pro-forma EBITDA consists of both organic and acquisition-based growth based on the last twelve months for all new acquisitions.

2) EBITDA as a ratio of net sales.